Clinical Innovations from bench to bedside
Clinical Innovations from bench to bedside: An introduction to developing therapeutics, medical devices and diagnostics
This seminar is part of the DCU Invent Insights on Innovation Series
Academic research can be the starting point for life-saving innovations across therapeutics, medical devices and diagnostics. However the long journey from lab to market can be daunting.
Prof. Alan Boyd and Eamonn McGowran have extensive experience in bringing these products to market, supporting both university spinouts and large multinationals. In this online seminar they will outline typical development pathways and highlight how decisions in early stage research can help or hinder translation to the clinic.They will touch on:
- Key changes in recent EU Medical Device Regulations
- Medical device categories and the varying regulatory requirements
- The role of the HPRA and when to engage with them
- Obtaining Assistance at European Medicine Agency for innovative therapies
- Considerations for planning academic research to facilitate translation to the clinic
Professor Alan Boyd
President and CEO, Boyd Consultants
Professor Alan Boyd, CEO of Boyd Consultants, is a Pharmaceutical Physician who has made leading contributions to developing medicines in industry, facilitated numerous drug development programmes with academics, and driven the recognition for the new specialty of Pharmaceutical Medicine. His contribution to medicines development has resulted in so far, around twenty products being licensed as prescription medicines and this includes eight cell and gene therapies.
Associate Director, Regulatory Affairs, Boyd Consultants
Greater than 20 years’ experience in pharmaceutical, biopharmaceutical, medical device, food and cosmetics sectors. In the last 7 years, has supported the regulatory and quality aspects of development and launch programmes (EU, US and RoW) for medical devices with medico-electrical and substance components.